Federal Register of Legislation - Australian Government

Primary content

PB 58 of 2021 Determinations/Health as made
This instrument amends the National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019 (PB 113 of 2019) to increase the safety net recording fee that an approved pharmacist may charge a patient in respect of the supply of certain pharmaceutical benefits, consistent with the requirements under the Seventh Community Pharmacy Agreement, with effect from 1 July 2021.
Administered by: Health
Registered 09 Jun 2021
Tabling HistoryDate
Tabled HR15-Jun-2021
Tabled Senate15-Jun-2021
To be repealed 25 Aug 2021
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 58 of 2021

 

National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Amendment Determination 2021

I, Mariana Crank, as delegate of the Minister for Health, make the following determination.

Dated 7 June 2021      

 

 

 

Mariana Crank

Acting Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Department of Health

 

 


 

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                            2

National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019  2

Subsection 6(1)(c)........................................................................................................................ 2


1  Name

(1)  This instrument is the National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Amendment Determination 2021.

(2)  This instrument may also be cited as PB 58 of 2021

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 July 2021.

1 July 2021.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 84C(7) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019

1  Subsection 6(1)(c)

Omit:

                            “(i)  if the pharmaceutical benefit is a ready‑prepared pharmaceutical benefit—$1.29; or

                             (ii)  if the pharmaceutical benefit is an extemporaneously‑prepared pharmaceutical benefit—$1.66.”

substitute:

                            “(i)  if the pharmaceutical benefit is a ready‑prepared pharmaceutical benefit—$1.30; or

                             (ii)  if the pharmaceutical benefit is an extemporaneously‑prepared pharmaceutical benefit—$1.67.”